RESULTS OF CLINICAL STUDY OF COMPLEX TREATMENT OF GENERALIZED PERIODONTITIS WITH THE USE OF STRONTIUM DRUGS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
The most significant periodontal disorders associated with diabetes mellitus are due to changes in bone tissue. It has become necessary for specific osteotropic therapy that can normalize metabolic processes in the alveolar bone. In turn, currently the most promising in terms of improving osteogenic activity are strontium ions. Strontium ranelate is used to treat osteoporosis due to its antiresorptive and osteoanabolic action. However, its effectiveness against alveolar bone has not been sufficiently studied.
The purpose of the work is to conduct a clinical study of complex treatment of generalized periodontitis, supplemented with strontium ranelate, in patients with type 2 diabetes mellitus.
Materials and methods of the research. The study included 60 patients with generalized periodontitis of I-II degree of severity, chronic course, aged 35-45 years. Type 2 diabetes mellitus was diagnosed and two groups were formed. The traditional treatment regimen was used in the group of comparison (main group) where Strontium Ranelate was prescribed additionally. The treatment was evaluated according to the dynamics of clinical observations, orthopantomography and computed tomography data, the results of biochemical studies. As markers of bone resorption, tartrate-resistant acid phosphatase (TRAP) activity was determined in blood serum and the content of β-CrossLaps fragments was determined in urine. As markers of osteogenesis, the concentration of C-terminal propeptide type I procollagen (CICP) was detected in blood plasma, bone alkaline phosphatase (BAP) and osteocalcin were detected in serum. Serum parathyroid hormone concentrations, total blood calcium and total inorganic phosphorus in the blood were studied as indicators of mineral metabolism.
Results of the research. In the earliest possible timeframe the complex treatment of generalized periodontitis was conducted during the observation which led to clinical stabilization of the inflammatorydestructive process in the periodontal tissues without a significant difference between the experimental groups (p ˃ 0.05). However, the condition of periodontal tissues in patients of the experimental groups differed in a year after treatment. In 16.7% of patients from the comparison group, recurrence of the inflammatory-destructive process in periodontal tissues was diagnosed, while the cases the deterioration of the pathological process was not detected in the main group. A significant difference was found for complex periodontal indices (Ramfjord, PI and SPITN) (p <0.05). Clinical and radiological stabilization was observed in 83.3% of patients of the comparison group and in 100% in the main group. According to the results of computed tomography of the alveolar bone, an increase in bone mineral density was established in both groups, but only in the main group the difference between indices before and after treatment was significant (p˂0.05).
In patients of the main group a more pronounced decrease in the activity of tartrate-resistant acid phosphatase (TRAP) was found in the serum and the concentration of β-CrossLaps was found in the urine, indicating inhibition of bone resorption, as well as markers of bone formation the concentration of C-terminal propeptide (CICP) was found in blood plasma, bone alkaline phosphatase (BAP) was found in serum, osteocalcin (p <0.05). Indicators of mineral metabolism in bone tissue, both during treatment and for experimental groups, almost did not differ (p> 0.05).
Thus, the use of strontium drugs in the complex treatment of generalized periodontitis in patients with type 2 diabetes mellitus provides a longer and more stable clinical and radiological stabilization of the pathological process in periodontal tissues, primarily by inhibiting bone resorption and enhancing osteogenesis. So, they can be recommended for the wide use in stomatological practice.
2. Slots J. Periodontitis: facts, fallacies and the future. Periodontology 2000. 2017; 75(1): 7-23.
3. Borisenko AV, Kuvaєv OS, Stoljar VG, Mjalkіvs'kij KO. Doslіdzhennja efektivnostі protizapal'noї kompozicії ta preparatu «Tantum Verde» v kompleksnіj terapії hvorih na parodontit. Suchasna stomatologіja. 2020; 5: 22-4. (Ukrainian).
4. Mashhenko IS, Gudar'jan AA, Dorogina AS. Prichiny ustojchivosti osnovnyh parodontal'nyh vozbuditelej k antibakterial'noj terapii u bol'nyh s bystroprogressirujushhim generalizovannym parodontitom. Vіsnik stomatologії. 2013; 4: 35-41. (Russian).
5. Nascimento GG, Leite FRM, Vestergaard P. Does diabetes increase the risk of periodontitis? A systematic review and meta-regression analysis of longitudinal prospective studies. Acta Diabetol. 2018; 55(7): 653-67.
6. Gudar'jan AA, Mashhenko IS, Shandyba SI. Generalizovannyj parodontit u bol'nyh saharnym diabetom 2 tipa: taktika i osobennosti hirurgicheskogo lechenija. Lambert Academic Publishing; 2019. 157 s. (Russian).
7. Polak D, Shapira L. An update on the evidence for pathogenic mechanisms that may link periodontitis and diabetes. Journal of Clinical Periodontology. 2018; 45 (2): 150-66.
8. WuYY, Xiao E, Graves DT. Diabetes mellitus related bone metabolism and periodontal disease. International Journal of Oral Science. 2015; 7: 6372.
9. Vinogradova OM, Shkrebenjuk RJu. Diferencіjnі metodi lіkuvannja zahvorjuvan' tkanin parodonta na tlі cukrovogo dіabetu. Klіnіchna ta eksperimental'na patologіja. 2015; № 1 (51): 205-8. (Ukrainian).
10. Romagnoli C, Zonefrati R, Galli G, Aldinucci A, Nuti N, Martelli FS [et al.]. The effect of strontium chloride on human periodontal ligament stem cells. Clinical Cases in Mineral and Bone Metabolism. 2017; 14 (3): 283-93.
11. Marins LM, Napimoga MH, Malta FS, Miranda TS, Nani EP, Franco BCT [et al.]. Effects of strontium ranelate on ligature-induced periodontitis in estrogen-deficient and estrogen-sufficient rats. Journal of Periodontal Reserch. 2020; 55(1): P. 141-51.
12. Wei L, Jiang Y, Zhou W, Liu S., Liu Y, Rausch-Fan X, Liu Z [et al.]. Strontium ion attenuates lipopolysaccharide-stimulated proinflammatory cytokine expression and lipopolysaccharideinhibited early osteogenic differentiation of human periodontal ligament cells. Journal of Periodontal Reserch. 2018; 53(6): 999-1008.
13. Jia X, Miron RJ, Yin C, Xu H, Luo T, Wang J [et al.]. Hn RNPL inhibits the osteogenic differentiation of PDLCs stimulated by SrCl2 through repressing Setd2. Journal of Cellular and Molecular Medicine. 2019; 23(4): 2667-77.
14. Karakan NC, Akpınar A, Göze F, Poyraz O. Investigating the effects of systemically administered strontium ranelate on alveolar bone loss histomorphometrically and histopathologically on experimental periodontitis in rats. Journal of Periodontology. 2017; 88(2): 24-31.
15. Matvyeyenko L. Effect of strontium ranelate on alveolar bone of rats with experimental general periodontitis. Collection of Scentific Works of International Conferencion “Modern Scientific Challenges and Trends”. Warsaw, 2021. Issue 12 (34). P.46-9.
16. Borisenko AV, redaktor. Terapevtichna stomatologіja: U 4-h t. T. 3: Zahvorjuvannja parodonta. K.: VSV «Medicina», 2018. 624 s. (Ukrainian).
17. Mashhenko IS. Bolezni parodonta. Drogobich: Kolo; 2008. 272 s. (Russian).
18. Chibisova MA, Orehova LJu, Serova NV. Osobennosti metodiki diagnosticheskogo obsledovanija pacientov s zabolevanijami parodonta na konusno-luchevom komp'juternom tomografe. Institut somatologii. 2014; 1 (62): 84-7. (Russian).
19. Antomonov MJu. Matematicheskaja obrabotka i analiz mediko-biologicheskih dannyh. K. 2006. 558 s. (Russian).
This work is licensed under a Creative Commons Attribution 4.0 International License.